CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC

CRYOVATE: A Pilot Study of Lung Cancer Cryoactivation in Combination With Immunotherapy in Advanced NSCLC

Introduction: NSCLC is the leading cause of cancer-related mortality. Although immune-checkpoint inhibitors (ICIs) have improved survival in patients with advanced NSCLC, treatment resistance remains a challenge. Cryoactivation, a technique inducing cell death by cycles of freezing and thawing, has...

Full description

Saved in:
Bibliographic Details
Main Authors: Antoine Desilets, MD, MSc, Gabryella Pinheiro, PhD, Wiam Belkaid, PhD, Olivier Salko, MD, Julie Malo, Eleyine Zarour, MD, Adeline Jouquan, MSc, Anne-Julie Thibaudeau, MSc, Marc-Antoine Nolin, MSc, John Stagg, PhD, Marie Florescu, MD, Mustapha Tehfe, MD, Normand Blais, MD, MSc, Samer Tabchi, MD, Jean Chalaoui, MD, Philippe Stephenson, MD, Arielle Elkrief, MD, Vincent Quoc-Huy Trinh, MD, MSc, Bertrand Routy, MD, PhD, Moishe Liberman, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:JTO Clinical and Research Reports
Subjects:
Cryoactivation
Immunotherapy
Immune checkpoint inhibitors
Non–small cell lung cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364324001073
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2666364324001073

Similar Items